Use App
Trending
News
Earnings
All
DIA
1.05%
SPY
0.13%
QQQ
1.73%
Trending
XLF
1.53%
PSNY
0.54%
JPM
0.12%
STLA
NTDOY
3.21%
MULL
11.74%
ETH
5.27%
TRUMP
0.73%
DOGE
1.52%
XLE
0.78%
XLF
1.53%
PSNY
0.54%
JPM
0.12%
STLA
NTDOY
3.21%
MULL
11.74%
ETH
5.27%
TRUMP
0.73%
DOGE
1.52%
XLE
0.78%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
GRI
news
Exchange:
NASDAQ
·
Updated 07:38 PM EDT
GRI
GRI Bio Inc
$1.87
$0.09
(5.06%)
Today
·
Closed $1.87
$0.0592
(3.17%)
After Hours
6
,
6
5
0
6
,
6
5
0
Mkt Cap
$3.31M
Vol
39,134.00
News
all
press releases
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Stocktwits
Full Article
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Benzinga
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
<
...
1
>
Latest GRI News
View
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
Stocktwits
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
Benzinga
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
Loading...
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile